Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Yebra, G. Parry, S. Strömblad, N. Mackman, S. Rosenberg, B. Mueller, D. Cheresh (1996)
Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration*The Journal of Biological Chemistry, 271
E. Clark, J. Brugge (1995)
Integrins and signal transduction pathways: the road taken.Science, 268 5208
J. Kim, K. Zhang, J. Chen, R. Kramer, D. Woodley (1994)
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor.The Journal of biological chemistry, 269 43
M.E.L. van der Burg, S.C. Henzen‐Logman, E.J.J. Berns, W.N.J. van Putten, J.G.M. Klijn (1996)
Expression of uPA and PAI‐1 in begnin, borderline, malignant primary and metastatic ovarian tumors, 69
A. Bartolazzi, J. Kaczmarek, G. Nicolò, A. Risso, G. Tarone, P. Rossino, P. Defilippi, P. Castellani (1993)
Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents.Anticancer research, 13 1
F. Carreiras, M. Lehmann, F. Sichel, J. Marvaldi, P. Gauduchon, J. Talaer (1995)
Implication of the αvβ3 integrin in the adhesion of the ovarian‐adenocarcinoma cell line IGROV1International Journal of Cancer, 63
D. Seiffert (1997)
Constitutive and regulated expression of vitronectin.Histology and histopathology, 12 3
L. Bafetti, Timothy Young, Y. Itoh, M. Stack (1998)
Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells*The Journal of Biological Chemistry, 273
M. Lehmann, C. Rabenandrasana, R. Tamura, J. Lissitzky, V. Quaranta, J. Pichon, J. Marvaldi (1994)
A Monoclonal Antibody Inhibits Adhesion to Fibronectin and Vitronectin of a Colon Carcinoma Cell Line and Recognizes the Integrins αvβ3, αvβ5, and αvβ6Cancer Research, 54
L. Kjøller, S. Kanse, T. Kirkegaard, K. Rodenburg, E. Rønne, S. Goodman, K. Preissner, L. Ossowski, P. Andreasen (1997)
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.Experimental cell research, 232 2
David Leavesley, M. Schwartz, M. Rosenfeld, D. Cheresh (1993)
Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanismsThe Journal of Cell Biology, 121
F. Carreiras, Y. Denoux, C. Staedel, M. Lehmann, F. Sichel, P. Gauduchon (1996)
Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma.Gynecologic oncology, 62 2
C. Bottini, S. Miotti, S. Fiorucci, P. Facheris, S. Ménard, M. Colnaghi (1993)
Polarization of the α6β4 integrin in ovarian carcinomasInternational Journal of Cancer, 54
F. Carreiras, M. Lehmann, F. Sichel, J. Marvaldi, P. Gauduchon, J. Talaer (1995)
Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1.International journal of cancer, 63 4
R. Bürk (1973)
A factor from a transformed cell line that affects cell migration.Proceedings of the National Academy of Sciences of the United States of America, 70 2
L. Kjoller, S.M. Kanse, T. Kirkegaard, K.W. Rodenburg, E. Ronne, S.L. Goodman, K.T. Preissner, L. Ossowski, P.A. Andreasen (1997)
PAI‐1 represses integrin and vitronectin‐mediated cell migration independently of its function as an inhibitor of plasminogen activation, 232
M. Lehmann, C. Rabenandrasana, R. Tamura, J. Lissitzky, V. Quaranta, J. Pichon, J. Marvaldi (1994)
A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.Cancer research, 54 8
C. Bottini, S. Miotti, S. Fiorucci, P. Facheris, S. Ménard, M. Colnaghi (1993)
Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas.International journal of cancer, 54 2
P.C. Brooks, S. Stromblad, L.C. Sanders, T.L.V. Schalscha, R.T. Aimes, W.G. Stetler‐Stevenson, J.P. Quigley, D.A. Cheresh (1996)
Localization of MMP‐2 to the surface of invasive cells by interaction with integrin αvβ3, 85
S. Palecek, J. Loftus, M. Ginsberg, D. Lauffenburger, A. Horwitz (1997)
Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesivenessNature, 385
P. Brooks, S. Strömblad, L. Sanders, T. Schalscha, R. Aimes, W. Stetler-Stevenson, J. Quigley, D. Cheresh (1996)
Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 85
J.S. Bauer, C.L. Schreiner, F.G. Giancotti, E. Ruoslahti, R.L. Juliano (1992)
Motility of fibronectin receptor‐deficient cells on fibronectin and vitronectin: collaborative interactions among integrins, 116
A. Huttenlocher, R. Sandborg, A. Horwitz (1995)
Adhesion in cell migration.Current opinion in cell biology, 7 5
T. Yatohgo, M. Izumi, Heihachiro Kashiwagi, Masao Hayashi (1988)
Novel purification of vitronectin from human plasma by heparin affinity chromatography.Cell structure and function, 13 4
W. Murdoch (1996)
OVARIAN SURFACE EPITHELIUM, OVULATION AND CARCINOGENESISBiological Reviews, 71
S. Mirshahi, K. Lounes, He Lu, E. Pujade-Lauraine, Z. Mishal, J. Bénard, A. Bernadou, C. Soria, J. Soria (1997)
Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase‐induced tyrosine phosphorylationFEBS Letters, 411
M. Burg, S. Henzen‐Logmans, E. Berns, W. Putten, J. Klijn, J. Foekens (1996)
Expression of urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in benign, borderline, malignant primary and metastatic ovarian tumorsInternational Journal of Cancer, 69
M. Yebra, G. Parry, S. Strömblad, N. Mackman, S. Rosenberg, B. Mueller, D. Cheresh (1996)
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.The Journal of biological chemistry, 271 46
Cell migration of ovarian tumoral cells is essential for cell dissemination and for invasion of the submesothelial extracellular matrix (ECM). We have conducted a study of the migratory properties of an ovarian adenocarcinoma cell line (IGROV1) by using 2 distinct methods for the evaluation of cell migration. We found that in a short‐term transfilter migration assay, IGROV1 cells migrated toward vitronectin, fibronectin, type IV collagen and laminin in an integrin‐dependent manner. When migration was evaluated in a wound healing assay, the restitution of the wounded area was stimulated solely by added, exogenous vitronectin and was almost totally dependent on αvβ3 integrin function. Moreover, we demonstrated that αvβ3 was localized in focal contacts restricted to the leading edge of migrating cells, whereas vitronectin notably localized with actin stress fibers and cortical actin. On the other hand, several kinase inhibitors were found to impede migration of IGROV1 induced by vitronectin. It thus appears that αvβ3–vitronectin interactions lead to the activation of multiple signaling pathway including activation of protein kinase C, phosphatidyl‐inositol‐3‐phosphate kinase and protein tyrosine kinase. The “αvβ3–vitronectin system” is therefore essential to the migration of human ovarian carcinoma cells.Int. J. Cancer 80:285–294, 1999. © 1999 Wiley‐Liss, Inc.
International Journal of Cancer – Wiley
Published: Jan 18, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.